352 related articles for article (PubMed ID: 2019232)
1. Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.
Riddle MC
Diabetes Res Clin Pract; 1991 Jan; 11(1):3-8. PubMed ID: 2019232
[No Abstract] [Full Text] [Related]
2. Treatment of non-insulin-dependent diabetes mellitus.
Davidson MB
Mayo Clin Proc; 1997 Jan; 72(1):92. PubMed ID: 9005295
[No Abstract] [Full Text] [Related]
3. [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
Ohmura E; Hosaka D; Imai Y; Kawazu S
Nihon Rinsho; 2002 Sep; 60 Suppl 9():470-5. PubMed ID: 12387036
[No Abstract] [Full Text] [Related]
4. Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor.
Riddle MC
Diabetes Care; 2008 Feb; 31 Suppl 2():S125-30. PubMed ID: 18227472
[No Abstract] [Full Text] [Related]
5. [Hypoglycemia: danger to life of diabetic patients. Higher price for blood sugar adjustment].
Füessl HS
MMW Fortschr Med; 2005 Aug; 147(31-32):4-6, 8. PubMed ID: 16128187
[No Abstract] [Full Text] [Related]
6. Triple oral anti-diabetic therapy in type 2 diabetes.
Barnett AH
Diabet Med; 2003 Jan; 20 Suppl 1():14-6. PubMed ID: 12647835
[No Abstract] [Full Text] [Related]
7. How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?
Bell DS; Ovalle F
Endocr Pract; 2000; 6(4):293-5. PubMed ID: 11242605
[TBL] [Abstract][Full Text] [Related]
8. Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas.
Bunnag P; Puavilai G; Chanprasertyotin S; Chandraprasert S; Suwanwalaikorn S; Suthijumroon A; Benjasuratwong Y; Boonyavarakul A; Nitiyanant W; Sriussadaporn S; Deerochanawong C;
Diabetes Res Clin Pract; 2001 Feb; 51(2):151-3. PubMed ID: 11253769
[No Abstract] [Full Text] [Related]
9. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
Ravina A; Minuhin O
Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
[No Abstract] [Full Text] [Related]
10. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea: response to Barnett et al.
Mikhail N; Cope D
Diabetes Care; 2006 Oct; 29(10):2332-3; author reply 2333. PubMed ID: 17003325
[No Abstract] [Full Text] [Related]
11. Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
Vos RC; Rutten GEHM
JAMA; 2017 Oct; 318(15):1489-1490. PubMed ID: 29049639
[TBL] [Abstract][Full Text] [Related]
12. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
[TBL] [Abstract][Full Text] [Related]
13. Diabetes care: what should we try to achieve?
O'Connor PJ
J Fam Pract; 1991 Oct; 33(4):343-4. PubMed ID: 1919448
[No Abstract] [Full Text] [Related]
14. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude.
Wallace TM; Matthews DR
QJM; 2000 Jun; 93(6):369-74. PubMed ID: 10873187
[No Abstract] [Full Text] [Related]
15. Insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failure.
Ravnik-Oblak M; Mrevlje F
Diabetes Res Clin Pract; 1995 Oct; 30(1):27-35. PubMed ID: 8745203
[TBL] [Abstract][Full Text] [Related]
16. Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent.
Osei K; Falko JM
Am J Med Sci; 1985 Apr; 289(4):148-53. PubMed ID: 3920907
[TBL] [Abstract][Full Text] [Related]
17. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
Arnolds S; Rave K
Lancet; 2008 Aug; 372(9636):370-1; author reply 372. PubMed ID: 18675680
[No Abstract] [Full Text] [Related]
18. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
Meneghini LF; Traylor L; Schwartz SL
Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients.
Kiayias JA; Vlachou ED; Theodosopoulou E; Lakka-Papadodima E
Diabetes Care; 2002 Jul; 25(7):1251-2. PubMed ID: 12087036
[No Abstract] [Full Text] [Related]
20. Clinical experience with exenatide in a routine secondary care diabetes clinic.
Natarajan B; Edavalath M; Davies J; Jenkins L; Marshall-Richards N; Evans D; Price DE; Bain SC; Stephens JW
Prim Care Diabetes; 2010 Apr; 4(1):57-60. PubMed ID: 20022310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
